Gene content    
PARK7 ( by HUGO)
Parkinson Protein 7
Oncogene
Parkinson Protein 7
Parkinson Disease (Autosomal Recessive
Early Onset) 7
Oncogene DJ1
DJ1
DJ-1
HEL-S-67p
Epididymis Secretory Sperm Binding Protein Li 67p
Protein DJ-1
EC 3.4.-.-
Parkinson Disease Protein 7
NCBI: 1p36.23    Ensembl: 1p36.23
PARK7_HUMANSize: 189 amino acidsMass: 19891 Da

  • Subunit: Homodimer. Binds EFCAB6/DJBP and PIAS2. Part of a ternary complex containing PARK7, EFCAB6/DJBP and AR. Interacts (via N-terminus) with OTUD7B. Interacts with BBS1, HIPK1, CLCF1 and MTERF Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for PARK7 (see all 27): 1J42 (3D) [IMAGE] 1P5F (3D) [IMAGE] 1PDV (3D) [IMAGE] 1PDW (3D) [IMAGE] 1PE0 (3D) [IMAGE] 1Q2U (3D) [IMAGE]
  • Tissue specificity: Highly expressed in pancreas, kidney, skeletal muscle, liver, testis and heart. Detected at slightly lower levels in placenta and brain. Detected in astrocytes, Sertoli cells, spermatogonia, spermatids and spermatozoa [IMAGE] Pathway & Disease-focused RT2
  • Function:
    UniProtKB/Swiss-Prot Summary: PARK7_HUMAN, Q99497 Function: Protects cells against oxidative stress and cell death. Plays a role in regulating expression or stability of the mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via L-type channels during pacemaking. Eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death. May act as an atypical peroxiredoxin-like peroxidase that scavenges hydrogen peroxide. Following removal of a C-terminal peptide, displays protease activity and enhanced cytoprotective action against oxidative stress-induced apoptosis. Stabilizes NFE2L2 by preventing its association with KEAP1 and its subsequent ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating activity. Enhances RELA nuclear translocation. Binds to a number of mRNAs containing multiple copies of GG or CC motifs and partially inhibits their translation but dissociates following oxidative stress. Required for correct mitochondrial morphology and function and for autophagy of dysfunctional mitochondria. Regulates astrocyte inflammatory responses. Acts as a positive regulator of androgen receptor-dependent transcription. Prevents aggregation of SNCA. Plays a role in fertilization. Has no proteolytic activity. Has cell-growth promoting activity and transforming activity. May function as a redox-sensitive chaperone. May regulate lipid rafts-dependent endocytosis in astrocytes and neuronal cells Biophysicochemical properties: Kinetic parameters: KM=173.4 uM for casein;
  • Similarity:
    Belongs to the peptidase C56 family [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR002818ThiJ/PfpIThiJ/PfpIDomain
    IPR006287DJ1DJ-1Family
    BlocksIPB002818Family of unknown function ThiJ/PfpIFamily of unknown function ThiJ/PfpI

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process cellular response to hydrogen peroxide IDA GOA 14749723
    cellular response to oxidative stress IDA GOA 15983381
    negative regulation of cell death IDA GOA 14749723
    negative regulation of proteasomal ubiquitin-dependent protein catabolic process IDA GOA 17015834
    negative regulation of protein binding IDA GOA 11477070
    negative regulation of protein binding IGI GOA 15983381
    negative regulation of protein export from nucleus IGI GOA 15983381
    negative regulation of protein kinase activity IGI GOA 15983381
    negative regulation of protein phosphorylation IGI GOA 15983381
    negative regulation of protein sumoylation IDA GOA 16731528
    negative regulation of protein ubiquitination IDA GOA 17015834
    positive regulation of sequence-specific DNA binding transcription factor activity IMP GOA 17015834
    positive regulation of transcription from RNA polymerase II promoter IGI GOA 15790595
    positive regulation of transcription from RNA polymerase II promoter IMP GOA 16731528
    protein stabilization IMP GOA 17015834
    Ras protein signal transduction TAS GOA 14662519
    regulation of androgen receptor signaling pathway IDA GOA 11477070
    regulation of neuron apoptotic process IDA GOA 18711745
    Cellular Component chromatin IDA GOA 16731528
    colocalizes_with mitochondrial respiratory chain complex I IDA GOA 19822128
    cytoplasm IDA GOA 12446870
    cytosol IDA GOA 14662519
    extracellular vesicular exosome IDA GOA 19056867
    mitochondrion IDA GOA 15790595
    nucleus IDA GOA 11477070
    Molecular Function androgen receptor binding IPI GOA 17510388
    enzyme binding IPI GOA 19703902
    identical protein binding IPI GOA 15983381
    mRNA binding IDA GOA 18626009
    NOT core promoter binding IC GOA 15790595
    protein binding IPI GOA 11477070
    protein homodimerization activity IDA GOA 18711745
    repressing transcription factor binding IPI GOA 15790595
    transcription coactivator activity TAS GOA 16731528
    transcription coactivator activity IGI GOA 15790595

    Disorder & Mutation    
    Source Disease
    SWISS-PROTParkinson disease 7 (PARK7) [MIM:606324]: A neurodegenerative disorder characterized by resting tremor, postural tremor, bradykinesia, muscular rigidity, anxiety and psychotic episodes. PARK7 has onset before 40 years, slow progression and initial good response to levodopa. Some patients may show traits reminiscent of amyotrophic lateral sclerosis-parkinsonism/dementia complex (Guam disease). Note=The disease is caused by mutations affecting the gene represented in this entry

    PARK7 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene